FRCP | MBChB | MRCP
Dr Aseem Malhotra is a visiting Consultant Cardiologist, and visiting Professor of Evidence Based Medicine, Bahiana School of Medicine and Public Health, Salvador, Brazil. He is a world renowned expert in the prevention, diagnosis and management of heart disease. He is honorary council member to the Metabolic Psychiatry Clinic at Stanford University school of medicine California, and is Cardiology MSc examiner at the University of Hertfordshire, UK. He is a founding member of Action on Sugar and was the lead campaigner highlighting the harm caused by excess sugar consumption in the United Kingdom, particularly its role in type 2 diabetes and obesity.
In 2015 he helped co-ordinate the Choosing Wisely campaign by the Academy of Medical Royal Colleges as lead author in a BMJ paper to highlight the risks of overuse of medical treatments. In the same year he became the youngest member to be appointed to the board of trustees of UK health think tank, The King’s Fund that advises government on health policy. Aseem is a frequent expert commentator in print and broadcast media and he has written scores of articles for a number of publications including the BMJ, British Journal of Sports Medicine, BMJ Open Heart, JAMA Internal Medicine, Prescriber, The Pharmaceutical Journal, European Scientist, The Guardian and Observer, BBC online, Huffington Post, The Daily Mirror, Daily Mail, The Daily Telegraph and the Washington Post. He is international guest editor of the journal of evidence-based healthcare.
Aseem has appeared in the Health Service Journal’s list of top 50 BME pioneers, and has won a number of awards for his work to raise awareness of diet-related illness both in the UK and internationally. He is a pioneer of the lifestyle medicine movement in the UK and has had feature articles written about him in the New York Times, The Guardian, The Telegraph, and Healthcare Leader. In 2018 he was ranked by software company Onalytica as the number 1 doctor in the world influencing obesity thinking.
In 2016 he was named in the Sunday Times Debrett’s list as one of the most influential people in science and medicine in the UK in a list that included Professor Stephen Hawking. His total Altmetric score (measure of impact and reach) of his medical journal publications since 2013 is over 10,000 making it one of the highest in the World for a clinical doctor during this period. His first book co-authored with Donal O’ Neill, The Pioppi Diet, has become an international best seller.
Award winning American Science Journalist Gary Taubes describes Aseem as someone who has “probably done more in the UK to inject sanity in to nutrition science and the pharmaceutical industry debate than any human being alive”
Sir Richard Thompson, Past President of the Royal College of Physicians and former personal physician to her majesty The Queen said “Dr Aseem Malhotra is changing the face of medicine and his revolutionary book the Pioppi Diet should be read by everyone”
Awards, Prizes and Recognitions
Here are some of the latest awards, prizes and recognitions of Dr Aseem Malhotra:
• Academic Excellence Award- British Association of Physicians of Indian Origin (BAPIO)- 2014
• Henry Schein Leadership Award for Young Doctors- British Association of Physicians of Indian Origin (BAPIO)- 2014
• “BME Pioneer” Health Services Journal- 2014
• “BME Pioneer” Health Services Journal- 2013
• Top 10 “Super Smart Set” London Evening Standard 1000 Power list – 2014
• “Food Hero” Children Food Campaign- 2013
• “Health Hero” Globe, Silver Star Diabetes Charity- 2013
Dr Aseem Malhotra strongly believes in patient information and personalized healthcare.
Dr Aseem Malhotra’s main areas of non-clinical work covered in 2014, have included the organization of seminars for NHS England CEO, Simon Stevens, on “Delivering New Models of Care”, and Improving the Health of NHS Staff in relation to the Five Year Forward view. He also wrote the executive summary and co-authored a report on International Hospital Standardized Mortality Rates for Professor Sir Bruce Keogh.